Tristel (TSTL) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Jul 2025 01:02 PM
RNS
Holding(s) in Company
26 Jun 2025 07:00 AM
RNS
APIC25 Annual Conference attendance
02 Jun 2025 07:00 AM
RNS
Investor Presentations & Notice of Trading Update
30 May 2025 07:00 AM
RNS
Holding(s) in Company
28 May 2025 07:00 AM
RNS
Conference attendance at Mello2025 Investor event
16 May 2025 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
15 May 2025 07:00 AM
RNS
CFO succession planning
12 May 2025 07:00 AM
RNS
FDA clearance for Tristel OPH
10 Apr 2025 07:00 AM
RNS
Additional info. submitted to FDA for Tristel OPH
09 Apr 2025 07:00 AM
RNS
Publication of Poster by Mayo Clinic & US update
02 Apr 2025 07:00 AM
RNS
Director/PDMR Shareholding
31 Mar 2025 08:56 AM
RNS
Holding(s) in Company
26 Mar 2025 10:30 AM
RNS
Director/PDMR Shareholding
18 Mar 2025 02:39 PM
RNS
Holding(s) in Company
24 Feb 2025 07:00 AM
RNS
Unaudited Interim Results
07 Feb 2025 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
23 Jan 2025 07:00 AM
RNS
Director Option Grant
13 Jan 2025 07:00 AM
RNS
Confirmation of Interim Results
16 Dec 2024 02:45 PM
RNS
Result of AGM
16 Dec 2024 07:00 AM
RNS
AGM Statement and Notice of Interim Results
22 Nov 2024 10:30 AM
RNS
Notice of AGM & Posting of Annual Report &Accounts
21 Nov 2024 01:32 PM
RNS
Exercise of Share Options and Total Voting Rights
20 Nov 2024 08:47 AM
RNS
Exercise of Share Options and Total Voting Rights
28 Oct 2024 01:37 PM
RNS
Exercise of Share Options and Total Voting Rights
21 Oct 2024 07:00 AM
RNS
Final Results
01 Oct 2024 07:00 AM
RNS
Notice of Preliminary Results
20 Sep 2024 07:00 AM
RNS
Director/PDMR Shareholding
19 Sep 2024 01:13 PM
RNS
Exercise of Share Options and Total Voting Rights
12 Sep 2024 07:00 AM
RNS
FDA 510(k) submission for Tristel OPH
02 Sep 2024 07:00 AM
RNS
Confirmation of CEO Transition, Directorate Change
06 Aug 2024 03:32 PM
RNS
Exercise of Share Options and Total Voting Rights
22 Jul 2024 07:00 AM
RNS
Trading Update
04 Jul 2024 03:43 PM
RNS
Exercise of Share Options and Total Voting Rights
11 Jun 2024 05:48 PM
RNS
Director/PDMR Shareholding
11 Jun 2024 03:50 PM
RNS
Holding(s) in Company
10 Jun 2024 07:00 AM
RNS
Appointment of CEO
08 May 2024 07:00 AM
RNS
Tristel™ ULT case study
07 May 2024 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
16 Apr 2024 02:04 PM
RNS
Director/PDMR Shareholding
15 Apr 2024 05:56 PM
RNS
Exercise of Share Options and Total Voting Rights
19 Mar 2024 09:25 AM
RNS
Exercise of Share Options and Total Voting Rights
19 Mar 2024 09:25 AM
RNS
Exercise of Share Options and Total Voting Rights
27 Feb 2024 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
26 Feb 2024 07:01 AM
RNS
Half-year Report
26 Feb 2024 07:00 AM
RNS
UK and EU regulatory approval update
08 Feb 2024 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
01 Feb 2024 07:00 AM
RNS
Notice of Interim Results
25 Jan 2024 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
23 Jan 2024 07:00 AM
RNS
Canadian regulatory approval for Tristel ULT
10 Jan 2024 02:27 PM
RNS
Director/PDMR Shareholding

Tristel plc is a global infection prevention company focused on manufacturing and supplying products using its proprietary chlorine dioxide (ClO2) chemistry, with a focus on medical device decontamination and surface disinfection.

Tristel share price launched at 46p in 2005.

UK 100

Latest directors dealings